DE69017434D1 - Immunosuppressant und verfahren zu seiner herstellung. - Google Patents

Immunosuppressant und verfahren zu seiner herstellung.

Info

Publication number
DE69017434D1
DE69017434D1 DE69017434T DE69017434T DE69017434D1 DE 69017434 D1 DE69017434 D1 DE 69017434D1 DE 69017434 T DE69017434 T DE 69017434T DE 69017434 T DE69017434 T DE 69017434T DE 69017434 D1 DE69017434 D1 DE 69017434D1
Authority
DE
Germany
Prior art keywords
alkyl
immunosuppressant
production
day
antagonist
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69017434T
Other languages
English (en)
Other versions
DE69017434T2 (de
Inventor
Hiroshi Nagase
Koji Kawai
Shu Matsumoto
Takashi Endoh
Yoshiaki Katsura
Kohei Arakawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toray Industries Inc
Original Assignee
Toray Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries Inc filed Critical Toray Industries Inc
Publication of DE69017434D1 publication Critical patent/DE69017434D1/de
Application granted granted Critical
Publication of DE69017434T2 publication Critical patent/DE69017434T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/09—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/20—Spiro-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Light Receiving Elements (AREA)
  • Amplifiers (AREA)
DE69017434T 1989-11-28 1990-11-28 Immunosuppressant und verfahren zu seiner herstellung. Expired - Fee Related DE69017434T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP30849189 1989-11-28
JP32216089 1989-12-11
JP32694189 1989-12-15
PCT/JP1990/001541 WO1991007966A1 (fr) 1989-11-28 1990-11-28 Immunosuppresseur et procede de preparation d'un tel medicament

Publications (2)

Publication Number Publication Date
DE69017434D1 true DE69017434D1 (de) 1995-04-06
DE69017434T2 DE69017434T2 (de) 1995-06-29

Family

ID=27338974

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69017434T Expired - Fee Related DE69017434T2 (de) 1989-11-28 1990-11-28 Immunosuppressant und verfahren zu seiner herstellung.

Country Status (14)

Country Link
US (1) US5332818A (de)
EP (1) EP0456833B1 (de)
JP (1) JP2906654B2 (de)
KR (1) KR940008032B1 (de)
AT (1) ATE119039T1 (de)
AU (1) AU639053B2 (de)
CA (1) CA2045481C (de)
DE (1) DE69017434T2 (de)
DK (1) DK0456833T3 (de)
ES (1) ES2069100T3 (de)
FI (1) FI913583A0 (de)
GR (1) GR3015266T3 (de)
NO (1) NO912940L (de)
WO (1) WO1991007966A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5852030A (en) * 1992-09-29 1998-12-22 Toray Industries, Inc. Indole derivatives, process for producing the same and medicinal uses of the same
WO1994007896A1 (en) 1992-09-29 1994-04-14 Toray Industries, Inc. Indole derivative, process for producing the same, and medicinal use thereof
KR950700065A (ko) * 1992-12-22 1995-01-16 마에다 카쭈노수케 진해제(Antitussive)
US5464841A (en) * 1993-11-08 1995-11-07 Univ Minnesota Use of delta opioid receptor antagonists to treat immunoregulatory disorders
SE9304236D0 (sv) * 1993-12-22 1993-12-22 Astra Ab New use
SE9401727D0 (sv) * 1994-05-18 1994-05-18 Astra Ab New compounds I
SE9401728D0 (sv) * 1994-05-18 1994-05-18 Astra Ab New compounds II
US5578725A (en) * 1995-01-30 1996-11-26 Regents Of The University Of Minnesota Delta opioid receptor antagonists
US5994327A (en) * 1995-11-17 1999-11-30 Astra Ab Process for the preparation of morphinans
CA2242609A1 (en) 1996-01-10 1997-07-17 Smithkline Beecham S.P.A. Heterocycle-condensed morphinoid derivatives (ii)
WO1998031684A1 (fr) * 1997-01-16 1998-07-23 Toray Industries, Inc. Derives d'indolomorphinane et medicaments/remedes preventifs contre les troubles cerebraux
US6172078B1 (en) 1997-03-31 2001-01-09 Toray Industries, Inc. Quinolinomorphinane derivatives and medicinal use thereof
US6359111B1 (en) 1998-05-28 2002-03-19 Neorx Corporation Opioid receptor targeting
US7232829B2 (en) 2001-04-06 2007-06-19 Regents Of The University Of Minnesota Therapeutic compounds and methods
US6809104B2 (en) 2001-05-04 2004-10-26 Tularik Inc. Fused heterocyclic compounds
US6858619B2 (en) 2001-05-04 2005-02-22 Amgen Inc. Fused heterocyclic compounds
JP2005530685A (ja) * 2002-01-25 2005-10-13 リージェンツ オブ ザ ユニバーシティ オブ ミネソタ 選択的鎮痛剤
CN1288158C (zh) * 2002-07-11 2006-12-06 东丽株式会社 用于预防恶心和呕吐的治疗剂或预防剂
BR0316070A (pt) 2002-11-06 2005-09-27 Tularik Inc Composto, composição farmacêutica, uso de um composto e, método para modular mchr
US20080045610A1 (en) * 2004-09-23 2008-02-21 Alexander Michalow Methods for regulating neurotransmitter systems by inducing counteradaptations
EP1809104A4 (de) * 2004-09-23 2009-04-29 Alexander Michalow Verfahren zum regeln von neurotransmittersystemen durch gegenadaptationen
CN1298718C (zh) * 2005-03-18 2007-02-07 中国科学院上海有机化学研究所 C环连接有吡嗪环的青藤碱衍生物、合成方法及其用途
US20070185145A1 (en) * 2006-02-03 2007-08-09 Royds Robert B Pharmaceutical composition containing a central opioid agonist, a central opioid antagonist, and a peripheral opioid antagonist, and method for making the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443605A (en) * 1982-07-30 1984-04-17 Miles Laboratories, Inc. 7β-Arylalkyl-6α, 7 α-oxymethylene-3-methoxy or 3-hydroxy-4, 5α-epoxy-17 methyl or 17-cycloalkyl-methyl morphinans
HU196376B (en) * 1985-05-23 1988-11-28 Sandoz Ag Process for preparing morphinane derivatives and pharmaceutical compositions containing such compounds
US4816586A (en) * 1987-07-29 1989-03-28 Regents Of The University Of Minnesota Delta opioid receptor antagonists
US4857533A (en) * 1988-12-15 1989-08-15 Baker Cummins Pharmaceuticals, Inc. Method of treatment for autoimmune diseases

Also Published As

Publication number Publication date
AU639053B2 (en) 1993-07-15
ATE119039T1 (de) 1995-03-15
FI913583A0 (fi) 1991-07-26
EP0456833B1 (de) 1995-03-01
CA2045481A1 (en) 1991-05-29
JP2906654B2 (ja) 1999-06-21
AU6876891A (en) 1991-06-26
NO912940D0 (no) 1991-07-29
EP0456833A4 (en) 1992-03-18
KR940008032B1 (ko) 1994-09-01
NO912940L (no) 1991-07-29
DK0456833T3 (da) 1995-05-01
CA2045481C (en) 1995-11-14
EP0456833A1 (de) 1991-11-21
KR920700643A (ko) 1992-08-10
GR3015266T3 (en) 1995-06-30
US5332818A (en) 1994-07-26
JPH03223288A (ja) 1991-10-02
DE69017434T2 (de) 1995-06-29
WO1991007966A1 (fr) 1991-06-13
ES2069100T3 (es) 1995-05-01

Similar Documents

Publication Publication Date Title
ATE119039T1 (de) Immunosuppressant und verfahren zu seiner herstellung.
ES2176204T3 (es) Antidepresivos que contienen un derivado de xantina.
DE69307444D1 (de) Siliciumnitrid-Sinterkörper und Verfahren zu seiner Herstellung
DE69901717T2 (de) Phosphohalohydrine, verfahren zu deren herstellung und verwendungen
DE69107647D1 (de) Magneto-elektrischer Übertrager und Verfahren zu seiner Herstellung.
ES2153071T3 (es) 2-amino-1,2,3,4-tetrahidronaftalenos y 3-aminocromanos sustituidos en anillo.
DE69105019D1 (de) Teilweise gehärteter Sinterkörper und Verfahren zu seiner Herstellung.
ATE155469T1 (de) Verfahren zur herstellung von cephemderivaten
HU9202199D0 (en) A new medical preparative containing benzomorphane
DE69201910D1 (de) Siliciumnitrid-Sinterkörper und Verfahren zu seiner Herstellung.
DE69634809D1 (de) Verfahren zur Herstellung von Platin Verbindungen
DE59005898D1 (de) Dinatriumsalz des Trimercapto-s-triazin-hexahydrats, Verfahren zu seiner Herstellung und Verwendung.
DE68912809D1 (de) Verfahren zur Herstellung von Bis(2,2,6,6-tetramethyl-4-piperidyl)amin.
HUP0303137A2 (hu) Kettős hatású antioxidáns és antiaritmiás szerek
ES2109244T3 (es) Medicamentos que contienen compuestos de 3,7-diazabiciclo(3,3,1)nonano.
DE3876276D1 (de) Heterocyclische neophananaloga, verfahren zu ihrer herstellung und ihre verwendung als schaedlingsbekaempfungsmittel.
DE69017404T2 (de) Diamantbeschichteter Sinterkörper und Verfahren zu seiner Herstellung.
WO2001097762A8 (de) Mittel zum färben von keratinhaltigen fasern enthaltend mindestens ein oxocyclopentenderivat

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee